Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT02859480
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Registry
-
NCT02859480
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02859480. Randomized; no masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2019-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
- Acronym
- ROSUVA-30
- Condition
- Coronary Artery Disease
- Condition
- Coronary Disease
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Rosuvastatin 5mg
- Intervention (Drug)
- Rosuvastatin 20mg
- Lead sponsor
- Korea University Anam Hospital
- Collaborator
- Samjin Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct02859480- Content hash
784781d0d6d4858b2266eadb492fd40ea3e3890b843676bfc22b110b9e4f3828